In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Corangin Nitrokapseln Drug Master File in Korea (Corangin Nitrokapseln KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Corangin Nitrokapseln. The MFDS reviews the Corangin Nitrokapseln KDMF as part of the drug registration process and uses the information provided in the Corangin Nitrokapseln KDMF to evaluate the safety and efficacy of the drug.
After submitting a Corangin Nitrokapseln KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Corangin Nitrokapseln API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Corangin Nitrokapseln suppliers with KDMF on PharmaCompass.